Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 09, 2022

SELL
$63.83 - $80.0 $50,106 - $62,800
-785 Reduced 13.77%
4,914 $316,000
Q1 2022

Apr 25, 2022

SELL
$76.85 - $89.45 $5,456 - $6,350
-71 Reduced 1.23%
5,699 $442,000
Q4 2021

Jan 26, 2022

SELL
$74.57 - $87.19 $9,992 - $11,683
-134 Reduced 2.27%
5,770 $495,000
Q3 2021

Oct 26, 2021

SELL
$73.77 - $83.61 $3,393 - $3,846
-46 Reduced 0.77%
5,904 $475,000
Q1 2021

Apr 29, 2021

BUY
$76.38 - $86.03 $11,151 - $12,560
146 Added 2.52%
5,950 $502,000
Q4 2020

Jan 26, 2021

SELL
$75.39 - $82.36 $7,539 - $8,236
-100 Reduced 1.69%
5,804 $466,000
Q3 2020

Nov 10, 2020

SELL
$78.33 - $90.73 $1,018 - $1,179
-13 Reduced 0.22%
5,904 $475,000
Q2 2020

Aug 07, 2020

BUY
$78.66 - $94.14 $465,431 - $557,026
5,917 New
5,917 $509,000

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $19.8B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Balasa Dinverno & Foltz LLC Portfolio

Follow Balasa Dinverno & Foltz LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balasa Dinverno & Foltz LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balasa Dinverno & Foltz LLC with notifications on news.